Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like Philips to Pay $62 Million to Resolve Charges of Violating U.S. Law in China May 12, 2023 Pacira Shutters DepCyt Operations After Years of Manufacturing Problems July 7, 2017 Aduhelm Gets Thumbs Down From EMA as Biogen Plans U.S. Confirmatory Study December 19, 2021